YU87001A - Mono i disupstituisane 3-propil gama-aminobuterne kiseline - Google Patents
Mono i disupstituisane 3-propil gama-aminobuterne kiselineInfo
- Publication number
- YU87001A YU87001A YU87001A YUP87001A YU87001A YU 87001 A YU87001 A YU 87001A YU 87001 A YU87001 A YU 87001A YU P87001 A YUP87001 A YU P87001A YU 87001 A YU87001 A YU 87001A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- disorders
- disubstituted
- mono
- aminobutyric acids
- propyl gamma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/20—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/32—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Abstract
Ovaj pronalazak je niz novih mono-i disupstituisanih 3-propil gama aminobuternih kiselina formule (I). Jedinjenja su korisna kao terapeutska sredstva pri lečenju epilepsije, napada nesvesti, hipokinezije, poremećaja lobanje, neurodegenerativnih poremećaja, depresije, uznemirenosti, panike, bola, neuropatoloških poremećaja, artritisa, poremećaja spavanja, IBS i želudačnih poremećaja. Takodje deo pronalaska su postupci za pripremanje jedinjenja i korisnih intermedijera.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13848599P | 1999-06-10 | 1999-06-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU87001A true YU87001A (sh) | 2004-07-15 |
RS50352B RS50352B (sr) | 2009-11-10 |
Family
ID=22482232
Country Status (43)
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7164034B2 (en) | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
US6620829B2 (en) | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
MXPA03011566A (es) * | 2001-06-11 | 2004-10-28 | Xenoport Inc | Formas de dosificacion de profarmacos de analogos de gaba administrados oralmente que tienen toxicidad reducida. |
ITMI20011308A1 (it) | 2001-06-21 | 2002-12-21 | Nicox Sa | Farmaci per il dolore cronico |
MXPA04004105A (es) * | 2002-01-31 | 2004-11-29 | Warner Lambert Co | Metodo de tratamiento de tinnitus. |
NI200300043A (es) | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
US20030225149A1 (en) * | 2002-04-30 | 2003-12-04 | Blazecka Peter G. | Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
US7071339B2 (en) | 2002-08-29 | 2006-07-04 | Warner Lambert Company Llc | Process for preparing functionalized γ-butyrolactones from mucohalic acid |
CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
ES2341240T3 (es) | 2002-12-13 | 2010-06-17 | Warner-Lambert Company Llc | Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior. |
RU2353358C2 (ru) | 2002-12-13 | 2009-04-27 | Уорнер-Ламберт Компани Ллс | Производные прегабалина для лечения приливов |
EP1572187A1 (en) * | 2002-12-13 | 2005-09-14 | Warner-Lambert Company LLC | Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
ITMI20022658A1 (it) | 2002-12-17 | 2004-06-18 | Nicox Sa | Farmaci per il dolore cronico. |
WO2005002585A1 (en) * | 2003-07-02 | 2005-01-13 | Warner-Lambert Company Llc | Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor |
KR100828218B1 (ko) | 2003-09-12 | 2008-05-07 | 화이자 인코포레이티드 | 알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물 |
CA2540247C (en) | 2003-09-25 | 2011-01-25 | Warner-Lambert Company Llc | Prodrugs of amino acids with affinity for the .alpha.2.delta.-protein |
OA13258A (en) * | 2003-09-25 | 2007-01-31 | Warner Lambert Co | Amino acids with affinity for the alpha2delta-protein. |
WO2006043171A2 (en) * | 2004-10-23 | 2006-04-27 | Warner-Lambert Company Llc | Methods of using alpha2delta-1 selective compounds |
EA016518B1 (ru) * | 2005-09-15 | 2012-05-30 | Юсб Фарма, С.А. | 4-замещенные пирролидин-2-оны и их применение |
US20070141684A1 (en) | 2005-12-21 | 2007-06-21 | Pfizer Inc | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein |
AR061728A1 (es) * | 2006-06-30 | 2008-09-17 | Pfizer Prod Inc | Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1 |
CN101600458A (zh) | 2006-12-22 | 2009-12-09 | 瑞蔻达蒂爱尔兰有限公司 | 采用α2δ配体和NSAID的下泌尿道疾病的联合治疗 |
WO2009136375A1 (en) * | 2008-05-08 | 2009-11-12 | Pfizer Inc | Treatment of interstitial cystitis |
EP2509596B1 (en) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma aminoacids for treating ocular disorders |
CN101914031B (zh) * | 2010-07-30 | 2013-08-28 | 中国广州分析测试中心 | 普瑞巴林衍生物及其应用 |
JP6800968B2 (ja) * | 2015-10-23 | 2020-12-16 | ナビター ファーマシューティカルズ, インコーポレイテッド | セストリン−gator2相互作用のモジュレーターおよびその使用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
WO1992009560A1 (en) * | 1990-11-27 | 1992-06-11 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
EP0641330B1 (en) * | 1992-05-20 | 2001-10-17 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
US5637767A (en) * | 1995-06-07 | 1997-06-10 | Warner-Lambert Company | Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
CN1094757C (zh) * | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
BR9712651A (pt) * | 1996-10-23 | 1999-10-26 | Warner Lambert Co | cidos gama-aminobutìricos substituìdos com agentes farmacêuticos. |
PL199794B1 (pl) * | 1997-10-27 | 2008-10-31 | Warner Lambert Co | Związki pośrednie do wytwarzania pochodnych cyklicznych aminokwasów |
-
2000
- 2000-05-31 CN CNB00808730XA patent/CN1196671C/zh not_active Expired - Fee Related
- 2000-05-31 EE EEP200100672A patent/EE200100672A/xx unknown
- 2000-05-31 DZ DZ003253A patent/DZ3253A1/fr active
- 2000-05-31 AT AT00938022T patent/ATE419231T1/de not_active IP Right Cessation
- 2000-05-31 AU AU53119/00A patent/AU776723C/en not_active Ceased
- 2000-05-31 KR KR1020017015841A patent/KR100694735B1/ko not_active IP Right Cessation
- 2000-05-31 IL IL14696900A patent/IL146969A0/xx active IP Right Grant
- 2000-05-31 BR BR0011727-7A patent/BR0011727A/pt not_active IP Right Cessation
- 2000-05-31 DE DE60041256T patent/DE60041256D1/de not_active Expired - Lifetime
- 2000-05-31 DK DK00938022T patent/DK1192125T3/da active
- 2000-05-31 HU HU0201601A patent/HUP0201601A3/hu unknown
- 2000-05-31 AP APAP/P/2002/002388A patent/AP1397A/en active
- 2000-05-31 PT PT00938022T patent/PT1192125E/pt unknown
- 2000-05-31 SK SK1764-2001A patent/SK287247B6/sk not_active IP Right Cessation
- 2000-05-31 EA EA200101134A patent/EA004398B1/ru not_active IP Right Cessation
- 2000-05-31 JP JP2001503818A patent/JP3904452B2/ja not_active Expired - Fee Related
- 2000-05-31 CN CNB2005100037011A patent/CN1310872C/zh not_active Expired - Fee Related
- 2000-05-31 UA UA2001128283A patent/UA72519C2/uk unknown
- 2000-05-31 MX MXPA01012319A patent/MXPA01012319A/es active IP Right Grant
- 2000-05-31 OA OA1200100326A patent/OA11962A/en unknown
- 2000-05-31 WO PCT/US2000/015070 patent/WO2000076958A2/en active Application Filing
- 2000-05-31 SK SK5045-2009A patent/SK287399B6/sk not_active IP Right Cessation
- 2000-05-31 CZ CZ20014285A patent/CZ300834B6/cs not_active IP Right Cessation
- 2000-05-31 NZ NZ515668A patent/NZ515668A/xx not_active IP Right Cessation
- 2000-05-31 EP EP00938022A patent/EP1192125B9/en not_active Expired - Lifetime
- 2000-05-31 CZ CZ20080760A patent/CZ301608B6/cs not_active IP Right Cessation
- 2000-05-31 RS RSP-2009/0257A patent/RS20090257A/sr unknown
- 2000-05-31 ME MEP-448/08A patent/MEP44808A/xx unknown
- 2000-05-31 CA CA2689997A patent/CA2689997A1/en not_active Abandoned
- 2000-05-31 TR TR2001/03587T patent/TR200103587T2/xx unknown
- 2000-05-31 ES ES00938022T patent/ES2317839T3/es not_active Expired - Lifetime
- 2000-05-31 RS YUP-870/01A patent/RS50352B/sr unknown
- 2000-05-31 GE GE4667A patent/GEP20074142B/en unknown
- 2000-05-31 CA CA2374755A patent/CA2374755C/en not_active Expired - Fee Related
- 2000-05-31 SI SI200031015T patent/SI1192125T1/sl unknown
- 2000-06-07 AR ARP000102808A patent/AR033335A1/es active IP Right Grant
- 2000-06-09 PE PE2000000577A patent/PE20010285A1/es not_active Application Discontinuation
- 2000-06-09 CO CO00043067A patent/CO5200791A1/es not_active Application Discontinuation
-
2001
- 2001-11-26 ZA ZA200109711A patent/ZA200109711B/en unknown
- 2001-11-28 IS IS6181A patent/IS6181A/is unknown
- 2001-12-05 NO NO20015949A patent/NO327746B1/no not_active IP Right Cessation
- 2001-12-06 CU CU20010291A patent/CU23101A3/es not_active IP Right Cessation
- 2001-12-06 IL IL146969A patent/IL146969A/en not_active IP Right Cessation
- 2001-12-07 CR CR6529A patent/CR6529A/es not_active Application Discontinuation
-
2002
- 2002-01-02 MA MA26462A patent/MA26804A1/fr unknown
- 2002-01-09 BG BG106292A patent/BG65561B1/bg unknown
- 2002-01-10 HR HR20020025A patent/HRP20020025A2/hr not_active Application Discontinuation
- 2002-10-30 HK HK02107862.8A patent/HK1046401B/zh not_active IP Right Cessation
-
2005
- 2005-09-29 HK HK05108612A patent/HK1076626A1/xx not_active IP Right Cessation
-
2009
- 2009-02-26 CY CY20091100228T patent/CY1108827T1/el unknown
- 2009-03-13 NO NO20091094A patent/NO20091094L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU87001A (sh) | Mono i disupstituisane 3-propil gama-aminobuterne kiseline | |
MX9806069A (es) | Novedosos amino acidos ciclicos substituidos como agentes farmaceuticos. | |
DE69921340D1 (de) | Verzweigte alkylpyrrolidin-3-carbonsäuren | |
GEP20043297B (en) | Bicyclic Amino Acids as Pharmaceutical Agents | |
HRP970560B1 (en) | Substituted gamma aminobutyric acids as pharmaceutical agents | |
ES2169848T3 (es) | Nuevos aminoacidos ciclicos coronados como agentes farmaceuticos. | |
PT888325E (pt) | Novos amino acidos ciclicos como agentes farmaceuiticos | |
CA2304965A1 (en) | ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders | |
TR200002570T2 (tr) | Glisin naklini önleyiciler | |
HUP0100786A2 (hu) | Helyettesített 2-fenil-1-(3,4-dihidroxi-5-nitrofenil)-1-etanonok, felhasználásuk egyes központi és perifériás idegrendszeri betegségek kezelésére és e vegyületeket tartalmazó gyógyszerkészítmények | |
ES2185591T3 (es) | Amino hererociclos utiles como agentes farmaceuticos. | |
RU95121818A (ru) | Новые триазолопирамидоны, их получение и применение | |
ECSP003522A (es) | Acidos 3- propilgamma- aminobutiricos mono- y, disustituidos |